Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycine Pour la Vie Des Enfants au Niger II
NCT06358872Phase 4Recruiting
- Sponsor
- University of California, San Francisco
- Start
- Apr 2024
- Primary completion
- Apr 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin in mortality, antimicrobial resistance (AMR), sponsored by University of California, San Francisco. Started Apr 2024; status: recruiting.
02
Drugs
azithromycin
03
Conditions
mortalityantimicrobial resistance (AMR)
Beyond the preview
Go deeper on NCT06358872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06358872.